Prime Minister Yoshihide Suga said Thursday that the government’s decision to suspend use of some 1.63 million doses of Moderna Inc.’s COVID-19 vaccine — a move that followed the discovery of foreign materials in one batch — will have little impact on its national vaccine rollout plans.
“I’ve received a report from the health ministry saying that it will not have a big impact,” Suga told reporters. “I have instructed the health ministry that safety is the top priority.”
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.
We humbly apologize for the inconvenience.